Go to AAD Home
Donate For Public and Patients Store Search
Go to AAD Home
Main menu
Membership
Meetings & Education
Practice management
Clinical & quality
Publications & apps
Career development
Advocacy
Back
Account
Pay dues
Member ID
Join the AAD
Member benefits
Find a member
AAD election
AAD governance
Support AAD
AAD Help Center
2025 Annual Meeting
2025 Innovation Academy
Academy meetings archive
Professional education
Claim CME & view transcript
Upcoming events
Residents & medical students
Patient education materials
DataDerm
Coding Resource Center
MIPS & fee schedule
Teledermatology
EHR & health tech
Insurance & drugs
Compliance & practice scope
Managing your practice
Clinical guidelines
Quality measures
DataDerm
Quality & patient safety
Clinical Community
Clinical care resources
Position statements
JAAD
JAAD International
JAAD Case Reports
Dermatology World
DermWorld Insights & Inquiries
Derm Coding Consult
DermWorld Meeting News
Impact Report
Other publications
Academy Apps
Job board
Join or sell a practice
Burnout & wellness
Career launch
Diversity
Awards, grants, and scholarships
Leadership Institute
Volunteer opportunities
Ethics & professionalism
Take action
Advocacy priorities
State advocacy resources
Legislative Conference
Position statements
Promote the specialty
Key Contacts
Patient advocate resources
SkinPAC
Advocacy Update
Welcome!

American Academy of Dermatology Association Statement on Reports on Counterfeit Injectables

American Academy of Dermatology President Seemal R. Desai, MD, FAAD

ROSEMONT, Ill. (Apr. 11, 2024) — The American Academy of Dermatology Association is alarmed by reports of patients suffering from illnesses resembling botulism after undergoing procedures that use possible counterfeit botulinum toxin, also known as botox. The concerning rise in counterfeit injectables poses a grave threat to patient safety, potentially resulting in severe complications such as visual impairment, blindness, infection or even stroke. These complications underscore the urgent need for patients to carefully understand who they are selecting to perform botox procedures.

Dermatologists pioneered the use of botox to relax wrinkles and to address conditions such as hyperhidrosis, and they have a long track record of safety and effectiveness. Botox injections are a medical procedure and should only be performed in a medical office by board-certified dermatologists or an appropriately trained non-physician clinician, under the direct on-site supervision of a board-certified dermatologist.

Patient safety is the top priority for the Academy and its member dermatologists, who have the most extensive medical training to avoid complications and provide patients with the best outcomes. The Academy cautions patients about the safety risks of seeking cosmetic treatments and encourages them to carefully consider the expertise of those providing care and the environment where that care is administered.

If you have questions about the safety or efficacy of any cosmetic procedure, schedule an appointment to see a board-certified dermatologist in your area.

About the AAD

Headquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential and most representative of all dermatologic associations. With a membership of more than 20,800 physicians worldwide, the AAD is committed to advancing the diagnosis and medical, surgical, and cosmetic treatment of the skin, hair, and nails; advocating high standards in clinical practice, education and research in dermatology; and supporting and enhancing patient care because skin, hair, and nail conditions can have a serious impact on your health and well-being. For more information, contact the AAD at (888) 462-DERM (3376) or aad.org. Follow @AADskin on Facebook, TikTok, Pinterest and YouTube and @AADskin1 on Instagram.

Editor’s note: The AAD does not promote or endorse any products or services. This content is intended as editorial content and should not be embedded with any paid, sponsored or advertorial content as it could be perceived as an AAD endorsement.